219 related articles for article (PubMed ID: 16557573)
1. Sex differences in risk of lung cancer: Expression of genes in the PAH bioactivation pathway in relation to smoking and bulky DNA adducts.
Mollerup S; Berge G; Baera R; Skaug V; Hewer A; Phillips DH; Stangeland L; Haugen A
Int J Cancer; 2006 Aug; 119(4):741-4. PubMed ID: 16557573
[TBL] [Abstract][Full Text] [Related]
2. Sex differences in susceptibility to PAHs is an intrinsic property of human lung adenocarcinoma cells.
Uppstad H; Osnes GH; Cole KJ; Phillips DH; Haugen A; Mollerup S
Lung Cancer; 2011 Mar; 71(3):264-70. PubMed ID: 20951464
[TBL] [Abstract][Full Text] [Related]
3. Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients.
Mollerup S; Ryberg D; Hewer A; Phillips DH; Haugen A
Cancer Res; 1999 Jul; 59(14):3317-20. PubMed ID: 10416585
[TBL] [Abstract][Full Text] [Related]
4. Role of estrogen receptor in regulation of polycyclic aromatic hydrocarbon metabolic activation in lung.
Berge G; Mollerup S; ØVrebø S; Hewer A; Phillips DH; Eilertsen E; Haugen A
Lung Cancer; 2004 Sep; 45(3):289-97. PubMed ID: 15301869
[TBL] [Abstract][Full Text] [Related]
5. Expression of CYP1A1, CYP1B1 and CYP3A, and polycyclic aromatic hydrocarbon-DNA adduct formation in bronchoalveolar macrophages of smokers and non-smokers.
Piipari R; Savela K; Nurminen T; Hukkanen J; Raunio H; Hakkola J; Mäntylä T; Beaune P; Edwards RJ; Boobis AR; Anttila S
Int J Cancer; 2000 Jun; 86(5):610-6. PubMed ID: 10797280
[TBL] [Abstract][Full Text] [Related]
6. Associations between smoking, polymorphisms in polycyclic aromatic hydrocarbon (PAH) metabolism and conjugation genes and PAH-DNA adducts in prostate tumors differ by race.
Nock NL; Tang D; Rundle A; Neslund-Dudas C; Savera AT; Bock CH; Monaghan KG; Koprowski A; Mitrache N; Yang JJ; Rybicki BA
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1236-45. PubMed ID: 17548691
[TBL] [Abstract][Full Text] [Related]
7. Characterization of CYP1B1 and CYP1A1 expression in human mammary epithelial cells: role of the aryl hydrocarbon receptor in polycyclic aromatic hydrocarbon metabolism.
Larsen MC; Angus WG; Brake PB; Eltom SE; Sukow KA; Jefcoate CR
Cancer Res; 1998 Jun; 58(11):2366-74. PubMed ID: 9622076
[TBL] [Abstract][Full Text] [Related]
8. Smoking-associated bulky DNA adducts in bronchial tissue related to CYP1A1 MspI and GSTM1 genotypes in lung patients.
Schoket B; Phillips DH; Kostic S; Vincze I
Carcinogenesis; 1998 May; 19(5):841-6. PubMed ID: 9635872
[TBL] [Abstract][Full Text] [Related]
9. Role of cytochrome p4501 family members in the metabolic activation of polycyclic aromatic hydrocarbons in mouse epidermis.
Kleiner HE; Vulimiri SV; Hatten WB; Reed MJ; Nebert DW; Jefcoate CR; DiGiovanni J
Chem Res Toxicol; 2004 Dec; 17(12):1667-74. PubMed ID: 15606143
[TBL] [Abstract][Full Text] [Related]
10. Comparison of polymorphisms in genes involved in polycyclic aromatic hydrocarbon metabolism with urinary phenanthrene metabolite ratios in smokers.
Hecht SS; Carmella SG; Yoder A; Chen M; Li ZZ; Le C; Dayton R; Jensen J; Hatsukami DK
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1805-11. PubMed ID: 17035385
[TBL] [Abstract][Full Text] [Related]
11. Quantitative RT-PCR measurement of cytochromes p450 1A1, 1B1, and 2B7, microsomal epoxide hydrolase, and NADPH oxidoreductase expression in lung cells of smokers and nonsmokers.
Willey JC; Coy EL; Frampton MW; Torres A; Apostolakos MJ; Hoehn G; Schuermann WH; Thilly WG; Olson DE; Hammersley JR; Crespi CL; Utell MJ
Am J Respir Cell Mol Biol; 1997 Jul; 17(1):114-24. PubMed ID: 9224217
[TBL] [Abstract][Full Text] [Related]
12. Human lung microsomal cytochrome P4501A1 (CYP1A1) activities: impact of smoking status and CYP1A1, aryl hydrocarbon receptor, and glutathione S-transferase M1 genetic polymorphisms.
Smith GB; Harper PA; Wong JM; Lam MS; Reid KR; Petsikas D; Massey TE
Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):839-53. PubMed ID: 11489750
[TBL] [Abstract][Full Text] [Related]
13. Polycyclic aromatic hydrocarbon-inducible DNA adducts: evidence by 32P-postlabeling and use of knockout mice for Ah receptor-independent mechanisms of metabolic activation in vivo.
Kondraganti SR; Fernandez-Salguero P; Gonzalez FJ; Ramos KS; Jiang W; Moorthy B
Int J Cancer; 2003 Jan; 103(1):5-11. PubMed ID: 12455047
[TBL] [Abstract][Full Text] [Related]
14. An improved fluorometric assay for dosimetry of benzo(a)pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity.
Alexandrov K; Rojas M; Geneste O; Castegnaro M; Camus AM; Petruzzelli S; Giuntini C; Bartsch H
Cancer Res; 1992 Nov; 52(22):6248-53. PubMed ID: 1423269
[TBL] [Abstract][Full Text] [Related]
15. Tissue specific induction of cytochrome P450 (CYP) 1A1 and 1B1 in rat liver and lung following in vitro (tissue slice) and in vivo exposure to benzo(a)pyrene.
Harrigan JA; McGarrigle BP; Sutter TR; Olson JR
Toxicol In Vitro; 2006 Jun; 20(4):426-38. PubMed ID: 16198082
[TBL] [Abstract][Full Text] [Related]
16. Induction of Cyp1a1 and Cyp1b1 and formation of DNA adducts in C57BL/6, Balb/c, and F1 mice following in utero exposure to 3-methylcholanthrene.
Xu M; Nelson GB; Moore JE; McCoy TP; Dai J; Manderville RA; Ross JA; Miller MS
Toxicol Appl Pharmacol; 2005 Nov; 209(1):28-38. PubMed ID: 15885734
[TBL] [Abstract][Full Text] [Related]
17. Induction of CYP1A1 and CYP1B1 and formation of carcinogen-DNA adducts in normal human mammary epithelial cells treated with benzo[a]pyrene.
Keshava C; Divi RL; Whipkey DL; Frye BL; McCanlies E; Kuo M; Poirier MC; Weston A
Cancer Lett; 2005 Apr; 221(2):213-24. PubMed ID: 15808407
[TBL] [Abstract][Full Text] [Related]
18. Analysis of DNA adducts in smokers' lung and urothelium by 32P-postlabelling: metabolic phenotype dependence and comparisons with other exposure markers.
Bartsch H; Castegnaro M; Camus AM; Schouft A; Geneste O; Rojas M; Alexandrov K
IARC Sci Publ; 1993; (124):331-40. PubMed ID: 8225503
[TBL] [Abstract][Full Text] [Related]
19. DNA adducts in tumour, normal peripheral lung and bronchus, and peripheral blood lymphocytes from smoking and non-smoking lung cancer patients: correlations between tissues and detection by 32P-postlabelling and immunoassay.
Gyorffy E; Anna L; Gyori Z; Segesdi J; Minárovits J; Soltész I; Kostic S; Csekeo A; Poirier MC; Schoket B
Carcinogenesis; 2004 Jul; 25(7):1201-9. PubMed ID: 15001535
[TBL] [Abstract][Full Text] [Related]
20. Expression of cytochromes P450 1A1 and 1B1 in human lung from smokers, non-smokers, and ex-smokers.
Kim JH; Sherman ME; Curriero FC; Guengerich FP; Strickland PT; Sutter TR
Toxicol Appl Pharmacol; 2004 Sep; 199(3):210-9. PubMed ID: 15364538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
